AI turns up a promising finding in cancer data that researchers hadn’t noticed for years

Kelly Paulson of Providence Swedish Cancer Institute examines an immunofluorescent image showing T-cells surrounding a lobular breast cancer tumor sample, confirming a finding flagged by Ai2’s AutoDiscovery system. (Ai2 Photo) An AI system built by Seattle’s Allen Institute for AI (Ai2) has found evidence that a common form of breast cancer, long thought to be a poor candidate for immunotherapy, might actually respond to it. The finding, produced by Ai2’s AutoDiscovery system, has led to an